Tenoten children's tab # 40

The drug has a sedative, anti-anxiety (anxiolytic) effect, without causing undesirable hypnogenic and muscle relaxant effects.

Improves the tolerance of psycho-emotional stress.

It has stress-protective, nootropic, antiamnesic, antihypoxic, neuroprotective, antiasthenic, antidepressant effects.

In conditions of intoxication, hypoxia, in conditions after an acute disturbance of cerebral circulation, it has a neuroprotective effect, limits the area of ​​damage, normalizes the processes of learning and memory in the central nervous system (CNS).

Inhibits the processes of lipid peroxidation.

Modifies the functional activity of the S-100 protein, which links synaptic (informational) and metabolic processes in the brain.

Providing GABA-mimetic and neurotrophic effects, it increases the activity of stress-limiting systems, helps to restore the processes of neuronal plasticity.

Name ENG

TENOTEN KID

Clinical and pharmacological group

Anxiolytic, nootropic drug

ATX code

Other psychostimulants and nootropic drugs, Other anxiolytics

Dosage

3mg

Structure

1 lozenge contains: active substance: antibodies to brain-specific protein S-100 affinity purified - 0.003 g * ,.

excipients: lactose, microcrystalline cellulose, magnesium stearate,.

* applied to lactose in the form of a water-alcohol mixture with a content of not more than 10-16 ng / g of the active form of the active substance.

Indications

Neurotic and neurosis-like disorders, accompanied by increased excitability, irritability, anxiety, impaired behavior and attention, autonomic disorders.

Contraindications

Individual hypersensitivity to the components of the drug, children under 3 years of age.

Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

INN / Active ingredient

Antibodies to brain-specific protein S-100 affinity purified

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Specifications

Category

Sedatives

,

Antipsychotics

,

Neurological disorders

Scope of the drug

Neurology, psychiatry

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

40

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Materia Medica Holding

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Nootropic agent

Anatomical and therapeutic characteristics

N06BX Other psychostimulants and nootropics

Dosage form

Lozenges

The target audience

Children

Expiration date in days

1095

Package weight, g

thirty

Mode of application

:

Inside.

At a time - 1 tablet (keep in the mouth until completely dissolved - not during meals).

If necessary, the tablet can be dissolved in a small amount of boiled water at room temperature. < br> Take from 1 to 3 times a day, the course of treatment is 1 to 3 months.

If necessary, the course of treatment can be extended up to 6 months or repeated after 1 - 2 months.

If there is no persistent improvement in the condition within 3-4 weeks after the start of treatment, you should consult a doctor.

Dosage (volume) of the substance in the preparation

:

Antibodies to brain-specific protein S-100 affinity purified - 0.003 g